##common.pageHeaderLogo.altText##

Original article

Vol. 155 No. 10 (2025)

Long COVID in children and adolescents: results from three cross-sectional school-based cohorts with adjudication

Cite this as:
Swiss Med Wkly. 2025;155:4337
Published
20.10.2025

Summary

STUDY AIMS: The prevalence of Long COVID in children and adolescents is heterogeneous, ranging from 1% to 51%, depending on the population studied. The lack of a standardised approach for establishing a Long COVID diagnosis in children and adolescents complicates the accurate assessment of prevalence, risk factors and outcomes. The present study aimed to examine the value of standardised interviews and an adjudication process to better understand self- or proxy-reported symptoms lasting longer than 12 weeks compatible with Long COVID in children and adolescents during the COVID-19 pandemic.

METHODS:We conducted a school-based, prospective cohort study (Ciao Corona) from March 2020 to July 2022 in the Canton of Zurich, Switzerland. Of 156 invited schools, 55 agreed to participate. Primary schools were randomly selected across all 12 districts of the Canton of Zurich, with nearby secondary schools subsequently invited. Within participating schools, classes were randomly selected, stratified by school level, and all students aged 6–17 years in selected classes were eligible. At three different time points (March/April 2021, November/December 2021 and June/July 2022), school-aged children and adolescents underwent serology testing and completed online questionnaires, including questions on symptoms lasting ≥12 weeks compatible with Long COVID. We invited those with persisting symptoms and who were seropositive for SARS-CoV-2 – whether “infected” i.e. infection and no vaccination or having “hybrid immunity” i.e. infection and vaccination – to participate in interviews to allow us to better understand the pattern, severity and timing of the reported symptoms. An adjudication process with experts then followed to assess the probability of Long COVID.

RESULTS: 39/1120 (3.5%) seropositive children and adolescents (i.e. infected or with hybrid immunity) reported persisting symptoms (≥12 weeks). The most frequently reported symptoms were headache, tiredness and stomach ache. In 20/39 (51%) with persisting symptoms who agreed to be interviewed, the adjudication committee concluded that Long COVID was unlikely in 13 (65%), possible in 7 (35%) and likely in 0 participants.

CONCLUSIONS: Relying exclusively on self- or proxy-reported questionnaire data, without more detailed information may overestimate Long COVID in children and adolescents. Implementing standardised interviews and an adjudication process helps to contextualise self- or proxy-reported symptoms compatible with Long COVID.

Trial registration: https://clinicaltrials.gov NCT04448717.

References

  1. 1. Zimmermann P, Curtis N. COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features. Pediatr Infect Dis J. 2020 Jun;39(6):469–77. doi: https://doi.org/10.1097/INF.0000000000002700
  2. 2. Bialek S, Boundy E, Bowen V, Chow N, Cohn A, Dowling N, et al.; CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020 Mar;69(12):343–6. doi: https://doi.org/10.15585/mmwr.mm6912e2
  3. 3. Neeland MR, Bannister S, Clifford V, Dohle K, Mulholland K, Sutton P, et al. Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children. Nat Commun. 2021 Feb;12(1):1084. doi: https://doi.org/10.1038/s41467-021-21414-x
  4. 4. Zimmermann P, Pittet LF, Curtis N. How Common is Long COVID in Children and Adolescents? Pediatr Infect Dis J. 2021 Dec;40(12):e482–7. doi: https://doi.org/10.1097/INF.0000000000003328
  5. 5. Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents. JAMA. 2021 Jul;326(9):869–71. doi: https://doi.org/10.1001/jama.2021.11880
  6. 6. Buonsenso D, Di Gennaro L, De Rose C, Morello R, D’Ilario F, Zampino G, et al. Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid. Future Microbiol. 2022 May;17(7):551–71. doi: https://doi.org/10.2217/fmb-2022-0031
  7. 7. Smane L, Roge I, Pucuka Z, Pavare J. Clinical features of pediatric post-acute COVID-19: a descriptive retrospective follow-up study. Ital J Pediatr. 2021 Aug;47(1):177. doi: https://doi.org/10.1186/s13052-021-01127-z
  8. 8. Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr. 2022 Apr;181(4):1597–607. doi: https://doi.org/10.1007/s00431-021-04345-z
  9. 9. Stephenson T, Pinto Pereira SM, Shafran R, de Stavola BL, Rojas N, McOwat K, et al.; CLoCk Consortium. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. 2022 Apr;6(4):230–9. doi: https://doi.org/10.1016/S2352-4642(22)00022-0
  10. 10. Kikkenborg Berg S, Palm P, Nygaard U, Bundgaard H, Petersen MN, Rosenkilde S, et al. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health. 2022 Sep;6(9):614–23. doi: https://doi.org/10.1016/S2352-4642(22)00154-7
  11. 11. Woodrow M, Carey C, Ziauddeen N, Thomas R, Akrami A, Lutje V, et al. Systematic Review of the Prevalence of Long COVID. Open Forum Infect Dis. 2023 May;10(7):ofad233. doi: https://doi.org/10.1093/ofid/ofad233
  12. 12. Twohig H, Bajpai R, Corp N, Faux-Nightingale A, Mallen C, Robinson T, et al. Long-term outcomes of COVID-19 infection in children and young people: a systematic review and meta-analysis. NIHR Open Res. 2024 Apr;4:22. doi: https://doi.org/10.3310/nihropenres.13549.1
  13. 13. Hahn LM, Manny E, Mamede F, Dhaliwal G, Chikuma J, Robinson JL, et al. Post-COVID-19 Condition in Children. JAMA Pediatr. 2023 Nov;177(11):1226–8. doi: https://doi.org/10.1001/jamapediatrics.2023.3239
  14. 14. Roessler M, Tesch F, Batram M, Jacob J, Loser F, Weidinger O, et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022 Nov;19(11):e1004122. doi: https://doi.org/10.1371/journal.pmed.1004122
  15. 15. Stephenson T, Shafran R, Ladhani SN. Long COVID in children and adolescents. Curr Opin Infect Dis. 2022 Oct;35(5):461–7. doi: https://doi.org/10.1097/QCO.0000000000000854
  16. 16. Pellegrino R, Chiappini E, Licari A, Galli L, Marseglia GL. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr. 2022 Dec;181(12):3995–4009. doi: https://doi.org/10.1007/s00431-022-04600-x
  17. 17. Azzam A, Khaled H, Refaey N, Mohsen S, El-Emam OA, Dawood N, et al. The burden of persistent symptoms after COVID-19 (long COVID): a meta-analysis of controlled studies in children and adults. Virol J. 2024 Jan;21(1):16. doi: https://doi.org/10.1186/s12985-024-02284-3
  18. 18. West EA, Anker D, Amati R, Richard A, Wisniak A, Butty A, et al.; Corona Immunitas Research Group. Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland. Int J Public Health. 2020 Dec;65(9):1529–48. doi: https://doi.org/10.1007/s00038-020-01494-0
  19. 19. Ulyte A, Radtke T, Abela IA, Haile SR, Braun J, Jung R, et al. Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study. Int J Public Health. 2020 Dec;65(9):1549–57. doi: https://doi.org/10.1007/s00038-020-01495-z
  20. 20. EQUATOR network. Enhancing the QUAlity and Transparency Of health Research [Internet]. [cited 2025 May 21]. Available from: https://www.equator-network.org/reporting-guidelines/
  21. 21. ISARIC. COVID-19 [Internet]. ISARIC.org. [cited 2024 Jul 8]. Available from: https://isaric.org/research/covid-19-clinical-research-resources/
  22. 22. Stephenson T, Allin B, Nugawela MD, Rojas N, Dalrymple E, Pinto Pereira S, et al.; CLoCk Consortium. Long COVID (post-COVID-19 condition) in children: a modified Delphi process. Arch Dis Child. 2022 Jul;107(7):674–80. doi: https://doi.org/10.1136/archdischild-2021-323624
  23. 23. WHO. WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus. WHO; 2021.
  24. 24. R Core Team. R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2022 [cited 2023 Mar 13]. Available from: https://www.R-project.org/
  25. 25. Coughlin SS. Recall bias in epidemiologic studies. J Clin Epidemiol. 1990;43(1):87–91. doi: https://doi.org/10.1016/0895-4356(90)90060-3
  26. 26. Althubaiti A. Information bias in health research: definition, pitfalls, and adjustment methods. J Multidiscip Healthc. 2016 May;9(May):211–7. doi: https://doi.org/10.2147/JMDH.S104807
  27. 27. Mack JW, McFatrich M, Withycombe JS, Maurer SH, Jacobs SS, Lin L, et al. Agreement Between Child Self-report and Caregiver-Proxy Report for Symptoms and Functioning of Children Undergoing Cancer Treatment. JAMA Pediatr. 2020 Nov;174(11):e202861. doi: https://doi.org/10.1001/jamapediatrics.2020.2861
  28. 28. Mockler GL, Novotny SP, Hou W, Liu Y, Schoenfeld ER. Patient Self-Report Superior to Electronic Medical Record Abstraction for Identifying Positive COVID-19 Symptoms at Illness Onset. AJPM Focus. 2022 Sep;1(1):100005. doi: https://doi.org/10.1016/j.focus.2022.100005
  29. 29. Barbara AM, Loeb M, Dolovich L, Brazil K, Russell M. Agreement between self-report and medical records on signs and symptoms of respiratory illness. Prim Care Respir J. 2012 Jun;21(2):145–52. doi: https://doi.org/10.4104/pcrj.2011.00098
  30. 30. Rosenman R, Tennekoon V, Hill LG. Measuring bias in self-reported data. Int J Behav Healthc Res. 2011 Oct;2(4):320–32. doi: https://doi.org/10.1504/IJBHR.2011.043414
  31. 31. Frei A, Siebeling L, Wolters C, Held L, Muggensturm P, Strassmann A, et al. The Inaccuracy of Patient Recall for COPD Exacerbation Rate Estimation and Its Implications: Results from Central Adjudication. Chest. 2016 Oct;150(4):860–8. doi: https://doi.org/10.1016/j.chest.2016.06.031
  32. 32. Raineri A, Radtke T, Rueegg S, Haile SR, Menges D, Ballouz T, et al. Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study. Nat Commun. 2023 Nov;14(1):7764. doi: https://doi.org/10.1038/s41467-023-43330-y